Obesity, NIDDM, Adipogenesis and Insulin Resistance - IBC's Ninth International Conference.
Approximately 70 representatives from industry and academia attended IBC's Ninth International Conference on Obesity, NIDDM, Adipogenesis and Insulin Resistance. It was characterized by intense and in-depth presentations on topics ranging from the costs (both human and financial) associated with obesity and diabetes and their complications to the use of animal models and progress in the identification/characterization of new drugs and/or drug targets. The conference was divided into three, distinct sessions, each of between six and eight talks, including an opening keynote address by Dr Susan Jebb on the etiology and implications of obesity treatment.
Watt
R
R
Current Drugs Ltd, Middlesex House, 34-42 Cleveland Street, London, W1P 6LB, UK. richard.watt@current-drugs.com